2017 annual financial data
Scinai Immunotherapeutics 2017 Operating margin
Scinai Immunotherapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,798,000 USD and net income was -9,930,000 USD.
Operating cash flow was -2,888,263 USD.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -6,798,000 USD
- Net income
- -9,930,000 USD
- Operating cash flow
- -2,888,263 USD